During the past decade, North Georgia Clinical Research conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 22 clinical trials were completed, i.e. on average, 122.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 15 clinical trials were completed. i.e. 187.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Georgia Clinical Research" #1 sponsor was "Pfizer" with 16 trials, followed by "Eli Lilly and Company" with 6 trials sponsored, "Forest Laboratories" with 2 trials sponsored, "Urovant Sciences GmbH" with 2 trials sponsored and "Aegerion Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Georgia Clinical Research" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 2 trials as a collaborator, "PPD" with 1 trials as a collaborator, "Syneos Health" with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "North Georgia Clinical Research" are "Osteoarthritis" (8 trials), "Arthritis" (4 trials), "Overactive Bladder" (4 trials), "Hypercholesterolemia" (3 trials) and "Osteoarthritis, Hip" (3 trials). Many other conditions were trialed in "North Georgia Clinical Research" in a lesser frequency.

Most popular intervention types in "North Georgia Clinical Research" are "Drug" (31 trials), "Biological" (11 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "tanezumab" (3 trials), "LY3857210" (2 trials), "Linaclotide" (2 trials) and "Naproxen" (2 trials). Other intervention names were less common.

The vast majority of trials in "North Georgia Clinical Research" are 35 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "North Georgia Clinical Research". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in North Georgia Clinical Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in North Georgia Clinical Research, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".